AHF Endorses Senate Committee Proposal to Detach R&D from Drug Pricing
AIDS Healthcare Foundation (AHF) has released the following statement regarding the U.S. Senate Health, Education, Labor, and Pensions (HELP) Committee's latest efforts to reauthorize the Pandemic and All-Hazards Preparedness Act (PAHPA):
"AIDS Healthcare Foundation welcomes the U.S. Senate HELP Committee's bipartisan approach to reauthorize pandemic preparedness legislation. The Pandemic and All-Hazards Preparedness Act will protect against disruptions to the nation's supply of critical pharmaceuticals," said Michael Weinstein, AHF president and cofounder. "AHF applauds U.S. Senators Bernie Sanders (I-Vt.) and Bill Cassidy (R-La.) for the prize research study provision within PAHPA that will evaluate new models for biomedical research that do not rely on the for-profit motives of drug companies. Alternatives to the traditional model that link R&D costs to drug prices will benefit all Americans."
AIDS Healthcare Foundation (AHF), the largest global HIV and AIDS organization, provides medical care and/or services to more that 1.7 million individuals in 45 countries worldwide in the US, Africa, Latin America/Caribbean, the Asia/Pacific Region, and Eastern Europe. To learn more about AHF, please visit our website, find us on Facebook, follow us on IG and Twitter, or subscribe to our "AHFter Hours" podcast.
An optimal vaginal microbiome is a key driver of gynecological, urogenital, and reproductive health
VS-01tm is a multi-strain probiotic and prebiotic clinically validated to establish an optimal vaginal microbiome and sustain regulated vaginal pH...
With 5.7 million electric vehicles (EVs) anticipated to be used in fleet applications by 2025, EV Connect, a leading EV charging business platform, and bp pulse, a global leader in charging infrastructure for fleets and public charging, today...
Cigent® Technology, Inc., the leader in cybersecurity for endpoints and storage devices, today announced the Cigent Endpoint Data Protection Platform that protects data from ransomware, data exfiltration, and data loss. The Endpoint Data Protection...
Ironwood Pharmaceuticals, Inc. , a GI-focused healthcare company, will present late-breaking data during the 2024 Digestive Disease Week® (DDW) meeting from its pivotal Phase III clinical trial, STARS, which evaluated the efficacy and safety of...
Ventegra, Inc., a Medical Benefit Manager (MBM) that delivers innovative, cost-efficient pharmaceutical and healthcare solutions to payors, providers, and members, announces it is the first to earn 2024 certification from HPfid's newly launched...
Netcracker Technology announced today that Ooredoo Qatar will extend its long-term partnership with Netcracker, utilizing Managed Services for Ooredoo's Revenue Management and CRM solutions to support B2C and B2B customers across a wide range of...
